pembro {nph}

Reconstructed Data Set Based On Survival Curves In Burtess et al. 2019

Description

The data set was approximately reconstructed from the survival curves shown in Figure 2D of Burtness et al. 2019 (see references). It contains survival times and event #' indicator under treatment with pembrolizumab (group 1) versus cetuximab with chemotherapy (group 0).

Usage

data(pembro)

Format

A data frame.

References

Burtness, B., Harrington, K. J., Greil, R., Soulières, D., Tahara, M., de Castro Jr, G., ... & Abel, E. (2019). Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. The Lancet, 394(10212), 1915-1928.

Examples

data(pembro)
head(pembro)